4 European Projects Found
Searched on 125080 European Projects
FINISHED
Standardization and Development of Assays for Assessment of Influenza Vaccines Correlates of Protection (FLUCOP)
Start date: Mar 1, 2015, End date: Feb 29, 2020,
Background: Influenza viruses cause annual epidemic and occasional pandemics, both of which induce significant morbidity and mortality. Influenza infections affect all age groups but children and adults over the age of 65 are at most risk of developing severe disease.Vaccination is the most effective approach to reduce the impact of annual influenza outbreaks and potential pandemics, however, the ...
Read Project
26
Partners Participants
FINISHED
Long-term effects of early nutrition on later health (EARLYNUTRITION)
Start date: Feb 1, 2012, End date: Oct 31, 2017,
Nutrition during early development has an important impact on later health, particularly through greater obesity risk, as demonstrated by FP6 EARNEST. EarlyNutrition explores the current key hypotheses on likely causes and pathways to prevention of early life origins of obesity (specifically adiposity) and associated disorders. We bring extraordinary expertise and study populations of 470,000 indi ...
Read Project
40
Partners Participants
FINISHED
Model-Based Social Learning for Public Administrations (Learn PAd)
Start date: Feb 1, 2014, End date: Oct 31, 2016,
In modern society public administrations (PAs) are undergoing a transformation of their perceived role from controllers to proactive service providers, and are under pressure to constantly improve their service quality while coping with quickly changing context (changes in law and regulations, societal globalization, fast technology evolution) and decreasing budgets. Civil servants are challenged ...
Read Project
9
Partners Participants
FINISHED
Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects (ADDUCE)
Start date: Nov 1, 2010, End date: Apr 30, 2016,
Attention deficit hyperactivity disorder (ADHD) is one of the most common neurodevelopmental disorders in children, affecting approximately 5% children in Europe. Methylphenidate (MPH) is the most-commonly prescribed medication for ADHD children; it is also increasingly used in ADHD adults. In 2007, the European Commission requested a referral to the Committee for Medicinal Products for Human Use ...
Read Project
